Citigroup Global Markets India Private Limited has Submitted to the Exchange a copy of Letter of Offer.

Open Offer TriggeredStrategic Transactions View source PDF Explain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹4951.10

prior close

₹4974.20

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%-0.1% vs market

Pharmaceuticals peers, median of 146sector+0.7%+0.0% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7+0.8-0.1+0.7+0.0

Next day

-0.2+1.6-1.8+1.2-1.4

-0.3+3.1-3.3+1.9-2.1

-0.0+4.0-4.0+2.1-2.2

-0.2+4.0-4.2+3.1-3.3

-0.0+4.4-4.5+4.3-4.3

-0.1+1.6-1.7+0.3-0.4

15d

-1.1-1.7+0.6-3.0+1.9

+0.4+8.1-7.7+3.4-3.0

+2.5+13.3-10.8+4.7-2.2

+3.1+16.9-13.8+8.2-5.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 146Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Citigroup Global Markets India Private Limited has submitted a Letter of Offer to the exchange in connection with Sanofi Consumer Healthcare India Limited. A Letter of Offer is filed under SEBI Takeover Regulations when an acquirer makes a mandatory open offer to public shareholders after crossing a shareholding threshold or triggering a change in control. Citigroup Global Markets appears to be acting as the manager to the open offer process.

Likely market impact

This signals that an open offer is underway for public shareholders of Sanofi Consumer Healthcare India. Eligible shareholders can tender their shares at the offer price during the offer window, which could lead to a potential re-rating of the stock depending on the offer premium.